Apixaban

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6381 publications

Comparing Hemostatic Efficacy of Four-Factor Prothrombin Complex Concentrate with Andexanet Alfa in an Apixaban-Treated Polytrauma Male Porcine Model.

Comparing Hemostatic Efficacy of Four-Factor Prothrombin Complex Concentrate with Andexanet Alfa in an Apixaban-Treated Polytrauma Male Porcine Model.

Journal: Anesthesiology
Published: April 15, 2026

Oncology: What You May Have Missed in 2025.

Oncology: What You May Have Missed in 2025.

Journal: Annals of internal medicine
Published: April 13, 2026

Use of Apixaban for Venous Thromboembolism Prophylaxis in an Older Hemodialysis Patient After Total Knee Replacement: A Case Report.

Use of Apixaban for Venous Thromboembolism Prophylaxis in an Older Hemodialysis Patient After Total Knee Replacement: A Case Report.

Journal: The American journal of case reports
Published: April 02, 2026

Unmasking Hypercoagulability: Superior Sagittal Sinus Thrombosis Attributed to Pernicious Anemia in a Patient With Normal Hemoglobin Levels.

Unmasking Hypercoagulability: Superior Sagittal Sinus Thrombosis Attributed to Pernicious Anemia in a Patient With Normal Hemoglobin Levels.

Journal: The American journal of case reports
Published: March 31, 2026

Apixaban-induced anaphylaxis.

Apixaban-induced anaphylaxis.

Journal: BMJ case reports
Published: March 31, 2026

Efficacy and safety of direct oral anticoagulants for intermediate stroke risk in patients with atrial fibrillation (SINGLE-AF): Study design and protocol.

Efficacy and safety of direct oral anticoagulants for intermediate stroke risk in patients with atrial fibrillation (SINGLE-AF): Study design and protocol.

Journal: Heart rhythm O2
Published: March 30, 2026

Extended Low-Dose Apixaban and Superficial Vein Thrombosis: Post Hoc Analysis of the HI-PRO Randomized Clinical Trial.

Extended Low-Dose Apixaban and Superficial Vein Thrombosis: Post Hoc Analysis of the HI-PRO Randomized Clinical Trial.

Journal: JAMA cardiology
Published: March 29, 2026

Possible Right Coronary Artery Supply to Pericardial Adipose Tissue Adjacent to an Abnormal Proximal Ascending Aortic Wall: A Case Report.

Possible Right Coronary Artery Supply to Pericardial Adipose Tissue Adjacent to an Abnormal Proximal Ascending Aortic Wall: A Case Report.

Journal: Cureus
Published: March 29, 2026

Inflation Reduction Act impact on the hematology/oncology treatment landscape.

Inflation Reduction Act impact on the hematology/oncology treatment landscape.

Journal: The American journal of managed care
Published: March 26, 2026

Apixaban (Eliquis) for Venous Thromboembolic Prophylaxis Following Abdominoplasty: Establishing a Safety and Efficacy Profile.

Apixaban (Eliquis) for Venous Thromboembolic Prophylaxis Following Abdominoplasty: Establishing a Safety and Efficacy Profile.

Journal: Plastic and reconstructive surgery
Published: March 26, 2026

Discrepant Outcomes of Direct Oral Anticoagulant Trials in Device-Detected Atrial Fibrillation after Stroke: Insights from NOAH-AFNET 6 and ARTESIA.

Discrepant Outcomes of Direct Oral Anticoagulant Trials in Device-Detected Atrial Fibrillation after Stroke: Insights from NOAH-AFNET 6 and ARTESIA.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: March 25, 2026

In Reply to: "Unmasking the Survival Benefit: Vascular Fragility and Selection Bias in Dialysis Anticoagulation" and "Apixaban Initiation in Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation".

In Reply to: "Unmasking the Survival Benefit: Vascular Fragility and Selection Bias in Dialysis Anticoagulation" and "Apixaban Initiation in Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation".

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: March 23, 2026
Showing 1-12 of 6,381

Last Updated: 04/28/2026